Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
50M
-
Number of holders
-
164
-
Total 13F shares, excl. options
-
51M
-
Shares change
-
+3.86M
-
Total reported value, excl. options
-
$2.29B
-
Value change
-
+$170M
-
Put/Call ratio
-
1.03
-
Number of buys
-
115
-
Number of sells
-
-48
-
Price
-
$44.95
Significant Holders of SOLENO THERAPEUTICS INC - Common Stock, par value $0.001 per share (SLNO) as of Q4 2024
215 filings reported holding SLNO - SOLENO THERAPEUTICS INC - Common Stock, par value $0.001 per share as of Q4 2024.
SOLENO THERAPEUTICS INC - Common Stock, par value $0.001 per share (SLNO) has 164 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 51M shares
.
Largest 10 shareholders include Vivo Capital, LLC (6.29M shares), JANUS HENDERSON GROUP PLC (5.19M shares), Nantahala Capital Management, LLC (3.93M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (2.78M shares), Avoro Capital Advisors LLC (2.53M shares), BlackRock, Inc. (2.01M shares), VANGUARD GROUP INC (1.88M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.63M shares), COMMODORE CAPITAL LP (1.53M shares), and PERCEPTIVE ADVISORS LLC (1.5M shares).
This table shows the top 164 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.